Results 161 to 170 of about 46,564 (215)

The Effects of <i>BRCA1</i> and <i>BRCA2</i> Promoter Methylation on Clinicopathological Characteristics and Clinical Outcomes in HGSOC. [PDF]

Cells
Živić K, Boljević I, Nedeljković M, Matović M, Janković R, Tanić M.   +5 more
europepmc   +1 more source

Drastic Response to Olaparib in a Patient With Metastatic Castration-Resistant Prostate Cancer Harboring BRCA2 Alterations and Near-Threshold Tumor Mutational Burden. [PDF]

IJU Case Rep
Yokota K, Kosaka T, Daimon T, Fujiwara S, Nakamura K, Nishihara H, Oya M.   +6 more
europepmc   +1 more source

Molecular characteristics and prognostic insights into BRCA-associated breast cancer in Kazakhstan. [PDF]

Sci Rep
Samigatova A, Altaeva N, Suleimenov Y, Sibiryakov P, Zhabagin K, Zhakypbekkyzy Z, Seksenbayev B, Yoshihiro N, Tsigengagel O.   +8 more
europepmc   +1 more source

Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer. [PDF]

J Immunother Cancer
Li C, Madan RA, Lee MJ, Lee S, Sato N, Rastogi S, Shrestha R, Aragon-Ching JB, Goswami M, Donahue RN, Cordes LM, Baj A, Seo CCY, Terrigino NT, Bright JR, Hennigan ST, King IM, Trostel SY, Fenimore JM, Liu Y, Calzone KA, Schlom J, Gulley JL, Dahut WL, Figg WD, Sowalsky AG, Lee JM, Karzai F.   +27 more
europepmc   +1 more source

Genetic Testing in Breast Cancer: Narrative Review and Clinical Insights. [PDF]

Maedica (Bucur)
Bistriceanu I, Ungureanu CO, Stoica RA, Giuglea C, Grigorean VT, Roca D, Mihaila R, Iordache N, Ginghina O.   +8 more
europepmc   +1 more source

Evaluation of quantitative polymerase chain reaction for detecting BRCA1 or BRCA2 copy number loss in high-grade serous ovarian cancer. [PDF]

Sci Rep
Oswald AJ, Hollis RL, Churchman M, Croy I, Ewing A, Thomson JP, Stillie LJ, Merry E, Albertella M, Forment JV, Roxburgh P, Semple CA, Herrington CS, Gourley C.   +13 more
europepmc   +1 more source

Durable complete radiographic and biochemical response to olaparib in BRCA2-mutated metastatic castration-resistant prostate cancer: a long-term responder case. [PDF]

Urol Case Rep
Ito F, Kobayashi K, Hayashi G, Kamijo S, Fujita T.   +4 more
europepmc   +1 more source

The Contribution of Genetic Modifiers to Ovarian Cancer Risk in <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variant Carriers. [PDF]

Cancers (Basel)
Cylwik D, Dwornik R, Białkowska K.
europepmc   +1 more source